Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check2 days agoChange Detected- Revision: v3.5.3 supersedes v3.5.2, indicating a minor administrative update to the study record on ClinicalTrials.gov. - The update does not change any study details or user-visible content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0 on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedAdded a Hepatocellular carcinoma tag and a link to the Genetic and Rare Diseases Information Center; updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.4.2 added, and the government funding lapse notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with a link to opm.gov for updates, and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.